“…Thus, pharmaceutical co-crystal technology has been demonstrated to be important in improving the poor solubility of NPX. NPX can form co-crystals or salts with the following CCFs or SFs, namely, nicotinamide [ 12 ], isonicotinamide [ 13 ] and picolinamide [ 14 ], duloxetine [ 15 ], and several chiral amino acids, including L-alanine [ 16 ], D-alanine, D-tyrosine, and D-tryptophan [ 17 ], arginine [ 18 ], zwitterionic prolinium [ 19 ], tramadol [ 20 ], bipyridine and piperazine [ 21 ], 4-amino pyridine and 2-amino pyridine [ 22 ], urea and thiourea [ 23 ]. SC XRD has been used to confirm the structures of most of these co-crystals or salts.…”